Eliot L. Gardner

Affiliations: 
Yeshiva University, New York, NY, United States 
Area:
Neuroscience Biology, Behavioral Psychology, Psychobiology Psychology
Google:
"Eliot Gardner"
Mean distance: 53433
 

Parents

Sign in to add mentor
Muriel Stern grad student 1962-1966 McGill
 (Donald Hebb was instrumental in directing this dissertation)

Children

Sign in to add trainee
Krista Spiller research assistant 2006-2009 NIH/NIDA
Stanislav R. Vorel grad student 2001 Yeshiva University
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li X, Hempel BJ, Yang HJ, et al. (2020) Dissecting the role of CB and CB receptors in cannabinoid reward versus aversion using transgenic CB- and CB-knockout mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Schweppe CA, Burzynski C, Jayanthi S, et al. (2020) Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms. Psychopharmacology
He Y, Galaj E, Bi GH, et al. (2019) Beta-caryophyllene, a dietary terpenoid, inhibits nicotine-taking and nicotine-seeking in rodents. British Journal of Pharmacology
Wang XF, Galaj E, Bi GH, et al. (2019) Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors. British Journal of Pharmacology
Xi ZX, Muldoon P, Wang XF, et al. (2019) Δ -Tetrahydrocannabivarin has potent anti-nicotine effects in multiple rodent models of nicotine dependence. British Journal of Pharmacology
Spiller KJ, Bi GH, He Y, et al. (2019) Cannabinoid CB and CB receptor mechanisms underlie cannabis reward and aversion in rats. British Journal of Pharmacology
You ZB, Bi GH, Galaj E, et al. (2018) Dopamine DR antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Uhl GR, Martinez MJ, Paik P, et al. (2018) Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist. Proceedings of the National Academy of Sciences of the United States of America
Gao JT, Jordan C, Bi GH, et al. (2018) Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Zhan J, Jordan CJ, Bi GH, et al. (2018) Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice. Neuropharmacology
See more...